Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 225

1.

Genetic Characterization of Measles and Rubella Viruses Detected Through Global Measles and Rubella Elimination Surveillance, 2016-2018.

Brown KE, Rota PA, Goodson JL, Williams D, Abernathy E, Takeda M, Mulders MN.

MMWR Morb Mortal Wkly Rep. 2019 Jul 5;68(26):587-591. doi: 10.15585/mmwr.mm6826a3.

2.

Extended delivery of vaccines to the skin improves immune responses.

Joyce JC, Sella HE, Jost H, Mistilis MJ, Esser ES, Pradhan P, Toy R, Collins ML, Rota PA, Roy K, Skountzou I, Compans RW, Oberste MS, Weldon WC, Norman JJ, Prausnitz MR.

J Control Release. 2019 Jun 28;304:135-145. doi: 10.1016/j.jconrel.2019.05.006. Epub 2019 May 6. French.

PMID:
31071375
3.

Accelerating measles and rubella elimination through research and innovation - Findings from the Measles & Rubella Initiative research prioritization process, 2016.

Grant GB, Masresha BG, Moss WJ, Mulders MN, Rota PA, Omer SB, Shefer A, Kriss JL, Hanson M, Durrheim DN, Linkins R, Goodson JL.

Vaccine. 2019 Mar 20. pii: S0264-410X(19)30167-7. doi: 10.1016/j.vaccine.2019.01.081. [Epub ahead of print]

PMID:
30904317
4.

Research priorities for accelerating progress toward measles and rubella elimination identified by a cross-sectional web-based survey.

Kriss JL, Grant GB, Moss WJ, Durrheim DN, Shefer A, Rota PA, Omer SB, Masresha BG, Mulders MN, Hanson M, Linkins RW, Goodson JL.

Vaccine. 2019 Mar 18. pii: S0264-410X(19)30265-8. doi: 10.1016/j.vaccine.2019.02.058. [Epub ahead of print]

PMID:
30898393
5.

Successes and challenges for preventing measles, mumps and rubella by vaccination.

Bankamp B, Hickman C, Icenogle JP, Rota PA.

Curr Opin Virol. 2019 Feb;34:110-116. doi: 10.1016/j.coviro.2019.01.002. Epub 2019 Mar 7. Review.

PMID:
30852425
6.

Use of FTA Cards To Transport Throat Swabs and Oral Fluid Samples for Molecular Detection and Genotyping of Measles and Rubella Viruses.

Bankamp B, Sein C, Pukuta Simbu E, Anderson R, Abernathy E, Chen MH, Muyembe Tamfum JJ, Wannemuehler KA, Waku-Kouomou D, Lopareva EN, Icenogle JP, Rota PA, Goodson JL.

J Clin Microbiol. 2019 Apr 26;57(5). pii: e00048-19. doi: 10.1128/JCM.00048-19. Print 2019 May.

PMID:
30814262
7.

Strengthening laboratory surveillance of viral pathogens: Experiences and lessons learned building next-generation sequencing capacity in Ghana.

Marine RL, Ntim NAA, Castro CJ, Attiku KO, Pratt D, Duker E, Agbosu E, Ng TFF, Gatei W, Obodai E, Odoom JK, Walker CL, Rota PA, Oberste MS, Ampofo WK, Balajee SA.

Int J Infect Dis. 2019 Apr;81:231-234. doi: 10.1016/j.ijid.2019.02.008. Epub 2019 Feb 15.

8.

Progress Toward Regional Measles Elimination - Worldwide, 2000-2017.

Dabbagh A, Laws RL, Steulet C, Dumolard L, Mulders MN, Kretsinger K, Alexander JP, Rota PA, Goodson JL.

MMWR Morb Mortal Wkly Rep. 2018 Nov 30;67(47):1323-1329. doi: 10.15585/mmwr.mm6747a6.

9.

Measles Outbreak at a Privately Operated Detention Facility: Arizona, 2016.

Venkat H, Briggs G, Brady S, Komatsu K, Hill C, Leung J, Patel M, Livar E, Su CP, Kassem A, Sowers SB, Mercader S, Rota PA, Elson D, Timme E, Robinson S, Fitzpatrick K, Franco J, Hickman C, Gastañaduy PA.

Clin Infect Dis. 2019 May 30;68(12):2018-2025. doi: 10.1093/cid/ciy819.

PMID:
30256908
10.

Differences in antigenic sites and other functional regions between genotype A and G mumps virus surface proteins.

Gouma S, Vermeire T, Van Gucht S, Martens L, Hutse V, Cremer J, Rota PA, Leroux-Roels G, Koopmans M, Binnendijk RV, Vandermarliere E.

Sci Rep. 2018 Sep 6;8(1):13337. doi: 10.1038/s41598-018-31630-z.

11.

Public health responses during measles outbreaks in elimination settings: Strategies and challenges.

Gastañaduy PA, Banerjee E, DeBolt C, Bravo-Alcántara P, Samad SA, Pastor D, Rota PA, Patel M, Crowcroft NS, Durrheim DN.

Hum Vaccin Immunother. 2018;14(9):2222-2238. doi: 10.1080/21645515.2018.1474310. Epub 2018 Jul 11. Review.

12.

A Microneedle Patch for Measles and Rubella Vaccination Is Immunogenic and Protective in Infant Rhesus Macaques.

Joyce JC, Carroll TD, Collins ML, Chen MH, Fritts L, Dutra JC, Rourke TL, Goodson JL, McChesney MB, Prausnitz MR, Rota PA.

J Infect Dis. 2018 Jun 5;218(1):124-132. doi: 10.1093/infdis/jiy139.

13.

A digital microfluidic system for serological immunoassays in remote settings.

Ng AHC, Fobel R, Fobel C, Lamanna J, Rackus DG, Summers A, Dixon C, Dryden MDM, Lam C, Ho M, Mufti NS, Lee V, Asri MAM, Sykes EA, Chamberlain MD, Joseph R, Ope M, Scobie HM, Knipes A, Rota PA, Marano N, Chege PM, Njuguna M, Nzunza R, Kisangau N, Kiogora J, Karuingi M, Burton JW, Borus P, Lam E, Wheeler AR.

Sci Transl Med. 2018 Apr 25;10(438). pii: eaar6076. doi: 10.1126/scitranslmed.aar6076.

PMID:
29695457
14.

Molecular characterisation of measles virus strains among refugees from Central African Republic in Cameroon in 2014.

Ndombo PK, Ndze VN, Mbarga FD, Anderson R, Acho A, Ebua Chia J, Njamnshi AK, Rota PA, Waku-Kouomou D.

Epidemiol Infect. 2018 Feb;146(3):319-323. doi: 10.1017/S0950268817002990. Epub 2018 Jan 9.

PMID:
29310739
15.

Evolutionary analysis of mumps viruses of genotype F collected in mainland China in 2001-2015.

Cui A, Rivailler P, Zhu Z, Deng X, Hu Y, Wang Y, Li F, Sun Z, He J, Si Y, Tian X, Zhou S, Lei Y, Zheng H, Rota PA, Xu W.

Sci Rep. 2017 Dec 7;7(1):17144. doi: 10.1038/s41598-017-17474-z.

16.

Notes from the Field: Absence of Asymptomatic Mumps Virus Shedding Among Vaccinated College Students During a Mumps Outbreak - Washington, February-June 2017.

Bonwitt J, Kawakami V, Wharton A, Burke RM, Murthy N, Lee A, Dell B, Kay M, Duchin J, Hickman C, McNall RJ, Rota PA, Patel M, Lindquist S, DeBolt C, Routh J.

MMWR Morb Mortal Wkly Rep. 2017 Dec 1;66(47):1307-1308. doi: 10.15585/mmwr.mm6647a5. No abstract available.

17.

Assessment of National Public Health and Reference Laboratory, Accra, Ghana, within Framework of Global Health Security.

Ogee-Nwankwo A, Opare D, Boateng G, Nyaku M, Haynes LM, Balajee SA, Conklin L, Icenogle JP, Rota PA, Waku-Kouomou D.

Emerg Infect Dis. 2017 Dec;23(13). doi: 10.3201/eid2313.170372.

18.

Progress Toward Regional Measles Elimination - Worldwide, 2000-2016.

Dabbagh A, Patel MK, Dumolard L, Gacic-Dobo M, Mulders MN, Okwo-Bele JM, Kretsinger K, Papania MJ, Rota PA, Goodson JL.

MMWR Morb Mortal Wkly Rep. 2017 Oct 27;66(42):1148-1153. doi: 10.15585/mmwr.mm6642a6.

19.

Mumps Outbreak in a Highly Vaccinated University-Affiliated Setting Before and After a Measles-Mumps-Rubella Vaccination Campaign-Iowa, July 2015-May 2016.

Shah M, Quinlisk P, Weigel A, Riley J, James L, Patterson J, Hickman C, Rota PA, Stewart R, Clemmons N, Kalas N, Cardemil C; Iowa Mumps Outbreak Response Team.

Clin Infect Dis. 2018 Jan 6;66(1):81-88. doi: 10.1093/cid/cix718.

PMID:
29020324
20.

Expansion of Surveillance for Vaccine-preventable Diseases: Building on the Global Polio Laboratory Network and the Global Measles and Rubella Laboratory Network Platforms.

Mulders MN, Serhan F, Goodson JL, Icenogle J, Johnson BW, Rota PA.

J Infect Dis. 2017 Jul 1;216(suppl_1):S324-S330. doi: 10.1093/infdis/jix077.

21.

Complete Genome Sequences of Mumps and Measles Virus Isolates from Three States in the United States.

Magaña LC, Espinosa A, Marine RL, Ng TFF, Castro CJ, Montmayeur AM, Hacker JK, Scott S, Whyte T, Bankamp B, Oberste MS, Rota PA.

Genome Announc. 2017 Aug 17;5(33). pii: e00748-17. doi: 10.1128/genomeA.00748-17.

22.

Global and national laboratory networks support high quality surveillance for measles and rubella.

Xu W, Zhang Y, Wang H, Zhu Z, Mao N, Mulders MN, Rota PA.

Int Health. 2017 May 1;9(3):184-189. doi: 10.1093/inthealth/ihx017. Review.

PMID:
28582561
23.

Subacute Sclerosing Panencephalitis.

Rota PA, Rota JS, Goodson JL.

Clin Infect Dis. 2017 Jul 15;65(2):233-234. doi: 10.1093/cid/cix307. No abstract available.

PMID:
28387848
24.

Perspective on Global Measles Epidemiology and Control and the Role of Novel Vaccination Strategies.

Coughlin MM, Beck AS, Bankamp B, Rota PA.

Viruses. 2017 Jan 19;9(1). pii: E11. doi: 10.3390/v9010011. Review.

25.

Antibodies Against Henipa-Like Viruses in Brazilian Bats.

de Araujo J, Lo MK, Tamin A, Ometto TL, Thomazelli LM, Nardi MS, Hurtado RF, Nava A, Spiropoulou CF, Rota PA, Durigon EL.

Vector Borne Zoonotic Dis. 2017 Apr;17(4):271-274. doi: 10.1089/vbz.2016.2051. Epub 2017 Jan 19.

PMID:
28103156
26.

Rapid Identification of Measles Virus Vaccine Genotype by Real-Time PCR.

Roy F, Mendoza L, Hiebert J, McNall RJ, Bankamp B, Connolly S, Lüdde A, Friedrich N, Mankertz A, Rota PA, Severini A.

J Clin Microbiol. 2017 Mar;55(3):735-743. doi: 10.1128/JCM.01879-16. Epub 2016 Nov 16.

27.

Progress Toward Regional Measles Elimination - Worldwide, 2000-2015.

Patel MK, Gacic-Dobo M, Strebel PM, Dabbagh A, Mulders MN, Okwo-Bele JM, Dumolard L, Rota PA, Kretsinger K, Goodson JL.

MMWR Morb Mortal Wkly Rep. 2016 Nov 11;65(44):1228-1233. doi: 10.15585/mmwr.mm6544a6.

28.

A Measles Outbreak in an Underimmunized Amish Community in Ohio.

Gastañaduy PA, Budd J, Fisher N, Redd SB, Fletcher J, Miller J, McFadden DJ 3rd, Rota J, Rota PA, Hickman C, Fowler B, Tatham L, Wallace GS, de Fijter S, Parker Fiebelkorn A, DiOrio M.

N Engl J Med. 2016 Oct 6;375(14):1343-1354.

29.
30.

Subacute Sclerosing Panencephalitis: The Foothold in Undervaccination.

Holt RL, Kann D, Rassbach CE, Schwenk HT, Ritter JM, Rota PA, Elbers J.

J Pediatr. 2016 Dec;179:259-262. doi: 10.1016/j.jpeds.2016.08.051. Epub 2016 Sep 12.

PMID:
27634625
31.

Measles.

Rota PA, Moss WJ, Takeda M, de Swart RL, Thompson KM, Goodson JL.

Nat Rev Dis Primers. 2016 Jul 14;2:16049. doi: 10.1038/nrdp.2016.49. Review.

PMID:
27411684
32.

High Concentrations of Measles Neutralizing Antibodies and High-Avidity Measles IgG Accurately Identify Measles Reinfection Cases.

Sowers SB, Rota JS, Hickman CJ, Mercader S, Redd S, McNall RJ, Williams N, McGrew M, Walls ML, Rota PA, Bellini WJ.

Clin Vaccine Immunol. 2016 Aug 5;23(8):707-16. doi: 10.1128/CVI.00268-16. Print 2016 Aug.

33.

Measles immunity among pregnant women aged 15-44 years in Namibia, 2008 and 2010.

Cardemil CV, Jonas A, Beukes A, Anderson R, Rota PA, Bankamp B, Gary HE Jr, Sawadogo S, Patel SV, Zeko S, Muroua C, Gaeb E, Wannemuehler K, Gerber S, Goodson JL.

Int J Infect Dis. 2016 Aug;49:189-95. doi: 10.1016/j.ijid.2016.05.020. Epub 2016 May 24.

34.

Rubella immunity among pregnant women aged 15-44 years, Namibia, 2010.

Jonas A, Cardemil CV, Beukes A, Anderson R, Rota PA, Bankamp B, Gary HE Jr, Sawadogo S, Patel SV, Zeko S, Muroua C, Gaeb E, Wannemuehler K, Gerber S, Goodson JL.

Int J Infect Dis. 2016 Aug;49:196-201. doi: 10.1016/j.ijid.2016.05.009. Epub 2016 May 16.

35.

Measles Outbreak Associated With Low Vaccine Effectiveness Among Adults in Pohnpei State, Federated States of Micronesia, 2014.

Hales CM, Johnson E, Helgenberger L, Papania MJ, Larzelere M, Gopalani SV, Lebo E, Wallace G, Moturi E, Hickman CJ, Rota PA, Alexander HS, Marin M.

Open Forum Infect Dis. 2016 Mar 24;3(2):ofw064. doi: 10.1093/ofid/ofw064. eCollection 2016 Mar.

36.

Global Measles and Rubella Laboratory Network Support for Elimination Goals, 2010-2015.

Mulders MN, Rota PA, Icenogle JP, Brown KE, Takeda M, Rey GJ, Ben Mamou MC, Dosseh AR, Byabamazima CR, Ahmed HJ, Pattamadilok S, Zhang Y, Gacic-Dobo M, Strebel PM, Goodson JL.

MMWR Morb Mortal Wkly Rep. 2016 May 6;65(17):438-42. doi: 10.15585/mmwr.mm6517a3.

37.

A Comparison of Postelimination Measles Epidemiology in the United States, 2009-2014 Versus 2001-2008.

Fiebelkorn AP, Redd SB, Gastañaduy PA, Clemmons N, Rota PA, Rota JS, Bellini WJ, Wallace GS.

J Pediatric Infect Dis Soc. 2017 Mar 1;6(1):40-48. doi: 10.1093/jpids/piv080.

38.

Progress toward regional measles elimination - worldwide, 2000-2014.

Perry RT, Murray JS, Gacic-Dobo M, Dabbagh A, Mulders MN, Strebel PM, Okwo-Bele JM, Rota PA, Goodson JL.

MMWR Morb Mortal Wkly Rep. 2015 Nov 13;64(44):1246-51. doi: 10.15585/mmwr.6444a4.

39.

Detection of Measles Virus RNA in Air and Surface Specimens in a Hospital Setting.

Bischoff WE, McNall RJ, Blevins MW, Turner J, Lopareva EN, Rota PA, Stehle JR Jr.

J Infect Dis. 2016 Feb 15;213(4):600-3. doi: 10.1093/infdis/jiv465. Epub 2015 Sep 19.

PMID:
26386428
40.

Effect of jet injection on infectivity of measles, mumps, and rubella vaccine in a bench model.

Coughlin MM, Collins M, Saxon G, Jarrahian C, Zehrung D, Cappello C, Dhere R, Royals M, Papania M, Rota PA.

Vaccine. 2015 Aug 26;33(36):4540-7. doi: 10.1016/j.vaccine.2015.07.013. Epub 2015 Jul 17.

PMID:
26192359
41.

Whole-Genome Sequencing During Measles Outbreaks.

Rota PA, Bankamp B.

J Infect Dis. 2015 Nov 15;212(10):1529-30. doi: 10.1093/infdis/jiv272. Epub 2015 Jul 6. No abstract available.

PMID:
26153410
42.

A 29-year-old pregnant woman with worsening left hemiparesis, encephalopathy, and hemodynamic instability: a case report of subacute sclerosing panencephalitis.

Reis GF, Ritter JM, Bellini WJ, Rota PA, Bollen AW.

Clin Neuropathol. 2015 Sep-Oct;34(5):258-66. doi: 10.5414/NP300843.

43.

A microneedle patch containing measles vaccine is immunogenic in non-human primates.

Edens C, Collins ML, Goodson JL, Rota PA, Prausnitz MR.

Vaccine. 2015 Sep 8;33(37):4712-8. doi: 10.1016/j.vaccine.2015.02.074. Epub 2015 Mar 12.

44.

Safety and immunogenicity of dry powder measles vaccine administered by inhalation: a randomized controlled Phase I clinical trial.

MVDP author group, Cape S, Chaudhari A, Vaidya V, Mulay R, Agarkhedkar S, Shermer C, Collins M, Anderson R, Agarkhedkar S, Kulkarni PS, Winston S, Sievers R, Dhere RM, Gunale B, Powell K, Rota PA, Papania M.

Vaccine. 2014 Nov 28;32(50):6791-7. doi: 10.1016/j.vaccine.2014.09.071. Epub 2014 Oct 22.

PMID:
25446830
45.

Genomic diversity of mumps virus and global distribution of the 12 genotypes.

Jin L, Örvell C, Myers R, Rota PA, Nakayama T, Forcic D, Hiebert J, Brown KE.

Rev Med Virol. 2015 Mar;25(2):85-101. doi: 10.1002/rmv.1819. Epub 2014 Nov 26. Review.

PMID:
25424978
46.

Progress toward regional measles elimination--worldwide, 2000-2013.

Perry RT, Gacic-Dobo M, Dabbagh A, Mulders MN, Strebel PM, Okwo-Bele JM, Rota PA, Goodson JL; Centers for Disease Control and Prevention (CDC).

MMWR Morb Mortal Wkly Rep. 2014 Nov 14;63(45):1034-8.

47.

Evolutionary genetics of genotype H1 measles viruses in China from 1993 to 2012.

Xu S, Zhang Y, Rivailler P, Wang H, Ji Y, Zhen Z, Mao N, Li C, Bellini WJ, Xu W, Rota PA.

J Gen Virol. 2014 Sep;95(Pt 9):1892-9. doi: 10.1099/vir.0.066746-0. Epub 2014 Jun 9.

48.

Measles - United States, January 1-May 23, 2014.

Gastañaduy PA, Redd SB, Fiebelkorn AP, Rota JS, Rota PA, Bellini WJ, Seward JF, Wallace GS; Division of Viral Disease, National Center for Immunization and Respiratory Diseases, CDC.

MMWR Morb Mortal Wkly Rep. 2014 Jun 6;63(22):496-9.

49.

Wild-type measles viruses with non-standard genome lengths.

Bankamp B, Liu C, Rivailler P, Bera J, Shrivastava S, Kirkness EF, Bellini WJ, Rota PA.

PLoS One. 2014 Apr 18;9(4):e95470. doi: 10.1371/journal.pone.0095470. eCollection 2014.

50.

Outbreak of measles among persons with prior evidence of immunity, New York City, 2011.

Rosen JB, Rota JS, Hickman CJ, Sowers SB, Mercader S, Rota PA, Bellini WJ, Huang AJ, Doll MK, Zucker JR, Zimmerman CM.

Clin Infect Dis. 2014 May;58(9):1205-10. doi: 10.1093/cid/ciu105. Epub 2014 Feb 27.

PMID:
24585562

Supplemental Content

Support Center